No Benefit With Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
Ann. Intern. Med 2021 Jan 26;[EPub Ahead of Print], H Al-Samkari, S Gupta, RK Leaf, W Wang, RP Rosovsky, SK Brenner, SS Hayek, H Berlin, R Kapoor, S Shaefi, ML Melamed, A Sutherland, J Radbel, A Green, BT Garibaldi, A Srivastava, A Leonberg-Yoo, AM Shehata, JE Flythe, A Rashidi, N Goyal, L Chan, KS Mathews, SS Hedayati, R Dy, SM Toth-Manikowski, J Zhang, M Mallappallil, RE Redfern, AD Bansal, SAP Short, MG Vangel, AJ Admon, MW Semler, KA Bauer, MA Hernán, DE LeafFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.